helicobacter-pylori

Documents about helicobacter-pylori

• Bleeding Ulcer and Erosions Study "BLUE Study"#148779ClinicalTrials.gov
• Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy#873685ClinicalTrials.gov
• Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era#895614ClinicalTrials.gov
• Antimicrobial Resistance Patterns and Predictors in <i>Helicobacter pylori</i> Infection: A Real-World Cohort Study#246388Europe PMC
• Tipificación del gen de la citotoxina vacuolizante de Helicobacter pylori por medio de la reacción en cadena de la polimerasa#462287Repositorio institucional Séneca
• Limited discriminative performance of endoscopic deep learning for Helicobacter pylori status assessment in gastric cancer patients: a retrospective study#482633HAL (France)
• Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches#625730Lund University Publications
• Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication#448291ClinicalTrials.gov
• A comparison of the efficacy and tolerability of quinolone-based triple therapy, quadruple therapy, and high-dose amoxicillin therapy in helicobacter pylori eradication#309500Recep Tayyip Erdoğan University Institutional Repository
• Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori#125897ClinicalTrials.gov
• H. Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study#836978ClinicalTrials.gov
• Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.#1031239ClinicalTrials.gov
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?#234462ClinicalTrials.gov
• First Time in Man Study of Finafloxacin Hydrochloride#849736ClinicalTrials.gov
• The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study#157991ClinicalTrials.gov
• 14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection#451500ClinicalTrials.gov
• Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients#895926ClinicalTrials.gov
• Detection of Helicopacter Pylori in Patients With Metabolic Associated Fatty Liver Disease#1045706ClinicalTrials.gov
• Prevalence and Predisposing Factors of <i>Helicobacter pylori</i> Infection in Symptomatic Patients: A Multicenter Study in Ghana's Upper East Region#205453Europe PMC
• Supporting data for Epidemiological Insights into the Global, Regional Burden and Temporal Trend of Helicobacter pylori Exposure and Gastrointestinal Diseases#333571Figshare
• Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.#1009671ClinicalTrials.gov
• Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians#18632ClinicalTrials.gov
• Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection#123505ClinicalTrials.gov
• A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children#174940ClinicalTrials.gov
• Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori#363641ClinicalTrials.gov
• Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori#1030001ClinicalTrials.gov
• Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study#858066ClinicalTrials.gov
• Determinación de la susceptibilidad antibiótica y su relación con la formación de biopelículas en cepas de Helicobacter pylori aisladas desde pacientes de la región de la Araucanía.#1040808Repositorio
• Test rapid ureaza helicobacter pylori#147271EU Publications
• Hpylori_dfliQ#356431CaltechDATA
• Hpylori_dFliM#356438CaltechDATA
• Hpylori_dflgS#356446CaltechDATA
• Hpylori_dfliG#1056842CaltechDATA
• Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection#377253ClinicalTrials.gov
• 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection#454043ClinicalTrials.gov
• Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity#811074ClinicalTrials.gov
• Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection#877753ClinicalTrials.gov
• Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study#858924ClinicalTrials.gov
• Bismuth Based Quadruple Therapy 10 Days in Children#184874ClinicalTrials.gov
• Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy#329544ClinicalTrials.gov
• Hpylori_dFliF_FISE#349831CaltechDATA
• Hpylori_dFliF_FISE#349833CaltechDATA
• Hpylori_dFliF_FISE#349865CaltechDATA
• Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test#908688ClinicalTrials.gov
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori#1007789ClinicalTrials.gov
• The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication#18626ClinicalTrials.gov
• High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population#172343ClinicalTrials.gov
• Effects of Fermented Rye Bran Products on Helicobacter Pylori (HP) Infection and Metabolic Risk Factors#966690ClinicalTrials.gov
• Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"#993943ClinicalTrials.gov
• Interleukin-8 expression differences in chronic and active chronic inflammation gastric mucosa biopsy with helicobacter pylori infection#930406Acta Interna: The Journal of Internal Medicine